Public publications of the anti -HIV prevention should be available for $ 40 annually in more than 100 countries from 2027, according to the Unitaid and Gates Foundation. The two organizations have concluded separate agreements with Indian pharmaceutical companies to produce general publications cheaper than Lenacapavir-injection twice a year showing that it reduces the risk of HIV transmission by more than 99.9 percent-for low and medium income countries. Details by direct executive Unitaid Philip Donateon.
[og_img]
Source link